Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasma cell | 16 studies | 44% ± 16% | |
fibroblast | 16 studies | 22% ± 10% | |
plasmablast | 8 studies | 35% ± 24% | |
IgA plasma cell | 7 studies | 26% ± 7% | |
endothelial cell | 7 studies | 26% ± 5% | |
IgG plasma cell | 6 studies | 27% ± 4% | |
myofibroblast cell | 5 studies | 20% ± 3% | |
oligodendrocyte | 5 studies | 20% ± 3% | |
smooth muscle cell | 4 studies | 19% ± 2% | |
pericyte | 4 studies | 19% ± 1% | |
epithelial cell | 4 studies | 32% ± 2% | |
retina horizontal cell | 4 studies | 25% ± 8% | |
glutamatergic neuron | 4 studies | 36% ± 12% | |
oligodendrocyte precursor cell | 4 studies | 23% ± 6% | |
connective tissue cell | 4 studies | 26% ± 13% | |
type B pancreatic cell | 3 studies | 33% ± 12% | |
GABAergic neuron | 3 studies | 40% ± 4% | |
dendritic cell | 3 studies | 23% ± 4% | |
neuron | 3 studies | 26% ± 7% | |
astrocyte | 3 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1956.08 | 328 / 328 | 100% | 39.88 | 178 / 178 |
prostate | 100% | 3145.73 | 245 / 245 | 100% | 60.24 | 502 / 502 |
breast | 100% | 3022.87 | 459 / 459 | 100% | 45.10 | 1117 / 1118 |
thymus | 100% | 4593.60 | 653 / 653 | 100% | 65.57 | 604 / 605 |
brain | 100% | 2917.36 | 2636 / 2642 | 100% | 57.15 | 705 / 705 |
lung | 100% | 3036.51 | 577 / 578 | 100% | 31.77 | 1154 / 1155 |
adrenal gland | 100% | 3829.91 | 258 / 258 | 100% | 73.56 | 229 / 230 |
ovary | 100% | 3248.90 | 180 / 180 | 100% | 23.54 | 428 / 430 |
kidney | 100% | 2328.42 | 89 / 89 | 99% | 48.22 | 896 / 901 |
uterus | 100% | 4168.57 | 170 / 170 | 99% | 29.56 | 456 / 459 |
bladder | 100% | 3379.19 | 21 / 21 | 99% | 25.90 | 500 / 504 |
stomach | 100% | 2239.94 | 359 / 359 | 99% | 22.77 | 283 / 286 |
liver | 99% | 1451.73 | 224 / 226 | 100% | 25.06 | 404 / 406 |
intestine | 100% | 2926.59 | 966 / 966 | 98% | 23.23 | 518 / 527 |
skin | 100% | 2685.01 | 1807 / 1809 | 97% | 40.05 | 457 / 472 |
esophagus | 100% | 2479.27 | 1444 / 1445 | 96% | 18.08 | 176 / 183 |
adipose | 100% | 3213.60 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4640.74 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 32.38 | 29 / 29 |
spleen | 100% | 3017.00 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.54 | 45 / 45 |
muscle | 100% | 1852.93 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 2664.32 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 19.14 | 70 / 80 |
peripheral blood | 67% | 959.31 | 627 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045880 | Biological process | positive regulation of smoothened signaling pathway |
GO_0060271 | Biological process | cilium assembly |
GO_0060170 | Cellular component | ciliary membrane |
GO_0005929 | Cellular component | cilium |
GO_0005515 | Molecular function | protein binding |
Gene name | TXNDC15 |
Protein name | Thioredoxin domain containing 15 Thioredoxin domain-containing protein 15 |
Synonyms | C5orf14 UNQ335/PRO534 |
Description | FUNCTION: Acts as a positive regulator of ciliary hedgehog signaling (By similarity). Involved in ciliogenesis . . |
Accessions | ENST00000358387.9 [Q96J42-1] ENST00000506916.1 ENST00000509954.1 D6RAV9 ENST00000507024.5 H0Y997 ENST00000508810.1 D6RBD9 D6R962 D6RB48 H0Y928 Q96J42 ENST00000508779.1 ENST00000511070.5 |